Federal Supply Schedule 36F79725D0145
Award Date
5/15/25
Last Date to Order
5/14/30
Federal Agency
Veterans Integrated Service Network 12
Awardee
Fresenius Kabi, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company based in Lake Zurich, Illinois. The contract has a ceiling value of $39,209,281.96 and a period of performance through July 29, 2030. Fresenius Kabi is the prime contractor tasked with manufacturing and distributing a variety of critical injectable medications and medical solutions to support military healthcare operations. The...
The National Acquisition Center of the Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company, for the supply of Bortezomib vials. The $2,237,072.60 contract covers a one-year base period from March 11, 2023, to March 10, 2024, with four one-year option periods. The contract is intended to provide an uninterrupted source of Bortezomib, a cancer treatment drug, to the VA, Department of Defense,...
The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract, identified as 36F79720D0075, to Vifor (International) AG, a Swiss-based pharmaceutical manufacturer. The contract, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), enables the VA to efficiently procure critical pharmaceutical products to support healthcare for veterans. Through this contract, Vifor (International) AG has received multiple delivery orders to supply various...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract, designated as V797D70253, falls under the Pharmaceuticals and Drugs FSS (FSS-61-IB), a government-wide acquisition vehicle. The task orders issued under this contract demonstrate Fresenius Kabi USA, LLC's role as a critical supplier of injectable pharmaceutical products, including...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business, is for the delivery of pharmaceutical and hematology-related products under Federal Supply Class 65 I B. The contract has a ceiling value of $225,000 and a period of performance through May 2028. In addition to the FSS contract, Nobelpharma America, LLC holds a single-award Blanket Purchase Agreement...
The Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract, valued at up to $3.5 million, to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company. The contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, facilitates the procurement of TARPEYO, an innovative treatment for uncontrolled protein in urine due to primary immunoglobulin A nephropathy, a serious renal condition impacting some veterans. In addition to the FSS...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
The Department of Veterans Affairs awarded a Federal Supply Schedule (FSS) contract to Hospira Worldwide LLC, a subsidiary of Pfizer Inc., for a wide range of pharmaceutical and medical products under the FSS-61 IB schedule. The $230 million multiple-award contract has a period of performance running from October 1, 2014 through June 30, 2024. Through this FSS contract, Hospira/Pfizer has provided sterile injectable drugs, antibiotics, anesthetics, IV solutions, and other medical supplies to...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Scpharmaceuticals Inc., a for-profit pharmaceutical company based in Lexington, MA, a Federal Supply Schedule (FSS) contract valued at $600,875.40. This multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract, designated as FSS 65 IB, covers the provision of drugs, pharmaceuticals, and hematology-related products to VA facilities over a five-year period ending in November 2028. In...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center has awarded a single-award Blanket Purchase Agreement (BPA) to Vifor (International) AG, a Swiss-based pharmaceutical manufacturer, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The $150,000 BPA, which expires on June 24, 2026, is specifically for the procurement of KORSUVA (difelikefalin), a medication used to treat pruritus. Additionally, Vifor (International) AG holds a separate $23.8 million...